Artiman Pharmed Alborz

Artiman Pharmed Alborz is an Iranian knowledge-based biotechnology company established in 2015 that specializes in the research, development, and manufacturing of high-quality biosimilars and novel biologics. The company leverages advanced mammalian cell culture, bioreactor fermentation, and purification technologies to address critical healthcare needs in oncology, immunology, endocrinology, and pulmonology. Its pipeline features prominent programs such as Dulagtima, a biosimilar dulaglutide undergoing clinical evaluation for type 2 diabetes, and Varasurf, a sheep-derived lung surfactant registered for respiratory distress syndrome. Artiman Pharmed Alborz operates out of headquarters in Tehran and manufacturing facilities in the Alborz region, adhering to strict Good Manufacturing Practice (GMP) standards. Through collaborations with leading academic institutions, the company aims to enhance patient access to affordable, life-saving biological therapies.